Cargando…
A tool for evaluating heterogeneity in avidity of polyclonal antibodies
Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978818/ https://www.ncbi.nlm.nih.gov/pubmed/36875126 http://dx.doi.org/10.3389/fimmu.2023.1049673 |
_version_ | 1784899602199085056 |
---|---|
author | Li, Kan Dodds, Michael Spreng, Rachel L. Abraha, Milite Huntwork, Richard H. C. Dahora, Lindsay C. Nyanhete, Tinashe Dutta, Sheetij Wille-Reece, Ulrike Jongert, Erik Ewer, Katie J. Hill, Adrian V. S. Jin, Celina Hill, Jennifer Pollard, Andrew J. Munir Alam, S. Tomaras, Georgia D. Dennison, S. Moses |
author_facet | Li, Kan Dodds, Michael Spreng, Rachel L. Abraha, Milite Huntwork, Richard H. C. Dahora, Lindsay C. Nyanhete, Tinashe Dutta, Sheetij Wille-Reece, Ulrike Jongert, Erik Ewer, Katie J. Hill, Adrian V. S. Jin, Celina Hill, Jennifer Pollard, Andrew J. Munir Alam, S. Tomaras, Georgia D. Dennison, S. Moses |
author_sort | Li, Kan |
collection | PubMed |
description | Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution tool (PAART) for use with label-free techniques, such as surface plasmon resonance and biolayer interferometry, that can monitor pAb-antigen interactions in real time to measure dissociation rate constant (k(d) ) for defining avidity. PAART utilizes a sum of exponentials model to fit the dissociation time-courses of pAb-antigens interactions and resolve multiple k(d) contributing to the overall dissociation. Each k(d) value of pAb dissociation resolved by PAART corresponds to a group of antibodies with similar avidity. PAART is designed to identify the minimum number of exponentials required to explain the dissociation course and guards against overfitting of data by parsimony selection of best model using Akaike information criterion. Validation of PAART was performed using binary mixtures of monoclonal antibodies of same specificity but differing in k(d) of the interaction with their epitope. We applied PAART to examine the heterogeneity in avidities of pAb from malaria and typhoid vaccinees, and individuals living with HIV-1 that naturally control the viral load. In many cases, two to three k(d) were dissected indicating the heterogeneity of pAb avidities. We showcase examples of affinity maturation of vaccine induced pAb responses at component level and enhanced resolution of heterogeneity in avidity when antigen-binding fragments (Fab) are used instead of polyclonal IgG antibodies. The utility of PAART can be manifold in examining circulating pAb characteristics and could inform vaccine strategies aimed to guide the host humoral immune response. |
format | Online Article Text |
id | pubmed-9978818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99788182023-03-03 A tool for evaluating heterogeneity in avidity of polyclonal antibodies Li, Kan Dodds, Michael Spreng, Rachel L. Abraha, Milite Huntwork, Richard H. C. Dahora, Lindsay C. Nyanhete, Tinashe Dutta, Sheetij Wille-Reece, Ulrike Jongert, Erik Ewer, Katie J. Hill, Adrian V. S. Jin, Celina Hill, Jennifer Pollard, Andrew J. Munir Alam, S. Tomaras, Georgia D. Dennison, S. Moses Front Immunol Immunology Diversity in specificity of polyclonal antibody (pAb) responses is extensively investigated in vaccine efficacy or immunological evaluations, but the heterogeneity in antibody avidity is rarely probed as convenient tools are lacking. Here we have developed a polyclonal antibodies avidity resolution tool (PAART) for use with label-free techniques, such as surface plasmon resonance and biolayer interferometry, that can monitor pAb-antigen interactions in real time to measure dissociation rate constant (k(d) ) for defining avidity. PAART utilizes a sum of exponentials model to fit the dissociation time-courses of pAb-antigens interactions and resolve multiple k(d) contributing to the overall dissociation. Each k(d) value of pAb dissociation resolved by PAART corresponds to a group of antibodies with similar avidity. PAART is designed to identify the minimum number of exponentials required to explain the dissociation course and guards against overfitting of data by parsimony selection of best model using Akaike information criterion. Validation of PAART was performed using binary mixtures of monoclonal antibodies of same specificity but differing in k(d) of the interaction with their epitope. We applied PAART to examine the heterogeneity in avidities of pAb from malaria and typhoid vaccinees, and individuals living with HIV-1 that naturally control the viral load. In many cases, two to three k(d) were dissected indicating the heterogeneity of pAb avidities. We showcase examples of affinity maturation of vaccine induced pAb responses at component level and enhanced resolution of heterogeneity in avidity when antigen-binding fragments (Fab) are used instead of polyclonal IgG antibodies. The utility of PAART can be manifold in examining circulating pAb characteristics and could inform vaccine strategies aimed to guide the host humoral immune response. Frontiers Media S.A. 2023-02-16 /pmc/articles/PMC9978818/ /pubmed/36875126 http://dx.doi.org/10.3389/fimmu.2023.1049673 Text en Copyright © 2023 Li, Dodds, Spreng, Abraha, Huntwork, Dahora, Nyanhete, Dutta, Wille-Reece, Jongert, Ewer, Hill, Jin, Hill, Pollard, Munir Alam, Tomaras and Dennison https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Li, Kan Dodds, Michael Spreng, Rachel L. Abraha, Milite Huntwork, Richard H. C. Dahora, Lindsay C. Nyanhete, Tinashe Dutta, Sheetij Wille-Reece, Ulrike Jongert, Erik Ewer, Katie J. Hill, Adrian V. S. Jin, Celina Hill, Jennifer Pollard, Andrew J. Munir Alam, S. Tomaras, Georgia D. Dennison, S. Moses A tool for evaluating heterogeneity in avidity of polyclonal antibodies |
title | A tool for evaluating heterogeneity in avidity of polyclonal antibodies |
title_full | A tool for evaluating heterogeneity in avidity of polyclonal antibodies |
title_fullStr | A tool for evaluating heterogeneity in avidity of polyclonal antibodies |
title_full_unstemmed | A tool for evaluating heterogeneity in avidity of polyclonal antibodies |
title_short | A tool for evaluating heterogeneity in avidity of polyclonal antibodies |
title_sort | tool for evaluating heterogeneity in avidity of polyclonal antibodies |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978818/ https://www.ncbi.nlm.nih.gov/pubmed/36875126 http://dx.doi.org/10.3389/fimmu.2023.1049673 |
work_keys_str_mv | AT likan atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT doddsmichael atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT sprengrachell atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT abrahamilite atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT huntworkrichardhc atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT dahoralindsayc atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT nyanhetetinashe atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT duttasheetij atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT willereeceulrike atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT jongerterik atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT ewerkatiej atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT hilladrianvs atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT jincelina atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT hilljennifer atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT pollardandrewj atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT muniralams atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT tomarasgeorgiad atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT dennisonsmoses atoolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT likan toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT doddsmichael toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT sprengrachell toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT abrahamilite toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT huntworkrichardhc toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT dahoralindsayc toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT nyanhetetinashe toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT duttasheetij toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT willereeceulrike toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT jongerterik toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT ewerkatiej toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT hilladrianvs toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT jincelina toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT hilljennifer toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT pollardandrewj toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT muniralams toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT tomarasgeorgiad toolforevaluatingheterogeneityinavidityofpolyclonalantibodies AT dennisonsmoses toolforevaluatingheterogeneityinavidityofpolyclonalantibodies |